Buscar resultados de ensayos clínicos

Patrocinado por

Salivary Gland Neoplasms - 16 Studies Found

Estado Estudiar
Completed Nombre del estudio: Activity of Sorafenib in Salivary Gland Cancer
Condición: Salivary Gland Cancer
Fecha: 2012-04-06
Intervenciones: Drug: Sorafenib 400 mg twice daily, on a continuous basis (each morning and evening), in 4 week cycles
Active, not recruiting Nombre del estudio: Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
Condición:
  • Recurrent Salivary Gland Cancer
  • Stage IVA Salivary Gland Cancer
  • Major Salivary Gland Carcinoma
  • Minor Salivary Gland Carcinoma
  • Biological: Ipilimumab Given I
Active, not recruiting Nombre del estudio: Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma
Condición: Salivary Gland Carcinoma
Fecha: 2015-03-13
Intervenciones: Drug: pazopanib treatment will be given until progression or unacceptable toxicity .
<<< Previous